Clinical Patterns and Treatment Outcome in Patients with Melancholic, Atypical and Non-Melancholic Depressions

Objective To assess sociodemographic, clinical and treatment factors as well as depression outcome in a large representative clinical sample of psychiatric depressive outpatients and to determine if melancholic and atypical depression can be differentiated from residual non-melancholic depressive conditions. Subjects/Materials and Method A prospective, naturalistic, multicentre, nationwide epidemiological study of 1455 depressive outpatients was undertaken. Severity of depressive symptoms was assessed by the Hamilton Depression Rating Scale (HDRS) and the Self Rated Inventory of Depressive Symptomatology (IDS-SR30). IDS-SR30 defines melancholic and atypical depression according to DSM-IV criteria. Assessments were carried out after 6–8 weeks of antidepressant treatment and after 14–20 weeks of continuation treatment. Results Melancholic patients (16.2%) were more severely depressed, had more depressive episodes and shorter episode duration than atypical (24.7%) and non-melancholic patients. Atypical depressive patients showed higher rates of co-morbid anxiety disorders and substance abuse. Melancholic patients showed lower rates of remission. Conclusion Our study supports a different clinical pattern and treatment outcome for melancholic and atypical depression subtypes.

[1]  B. Harald,et al.  Meta-review of depressive subtyping models. , 2012, Journal of affective disorders.

[2]  J. Flint,et al.  A COMPARISON OF MELANCHOLIC AND NONMELANCHOLIC RECURRENT MAJOR DEPRESSION IN HAN CHINESE WOMEN , 2011, Depression and anxiety.

[3]  M. Roca,et al.  Clinical differences between early and late remission in depressive patients. , 2011, Journal of affective disorders.

[4]  J. Luciano,et al.  Psychometric properties of the IDS-SR30 for the assessment of depressive symptoms in spanish population , 2011, BMC medical research methodology.

[5]  Álvaro I. Langer,et al.  El typus melancholicus de Tellenbach en la actualidad:: una revisión sobre la personalidad premórbida vulnerable a la melancolía , 2011 .

[6]  M. Rietschel,et al.  Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. , 2011, Journal of affective disorders.

[7]  G. Parker.  Classifying clinical depression: an operational proposal , 2011, Acta psychiatrica Scandinavica.

[8]  M. Maj.  Refining the diagnostic criteria for major depression on the basis of empirical evidence , 2011, Acta psychiatrica Scandinavica.

[9]  J. Kocsis.  Melancholia as a distinct mood disorder? Recommendations for DSM-5. , 2010, The American journal of psychiatry.

[10]  M. Roca,et al.  Melancholic versus non-melancholic depression: differences on cognitive function. A longitudinal study protocol , 2010, BMC Psychiatry.

[11]  M. Breakspear,et al.  Inching toward Bethlehem: mapping melancholia. , 2010, Journal of affective disorders.

[12]  M. Fava,et al.  Do atypical features affect outcome in depressed outpatients treated with citalopram? , 2010, The international journal of neuropsychopharmacology.

[13]  F. Quitkin,et al.  DSM-IV Depression with Atypical Features: Is It Valid? , 2009, Neuropsychopharmacology.

[14]  Z. Segal,et al.  A novel examination of atypical major depressive disorder based on attachment theory. , 2009, The Journal of clinical psychiatry.

[15]  M. Fava,et al.  Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. , 2008, The Journal of clinical psychiatry.

[16]  M. Thase,et al.  Primary care patients' personal illness models for depression: relationship to coping behavior and functional disability. , 2007, General hospital psychiatry.

[17]  M. Fava,et al.  Acupuncture for major depressive disorder: has its efficacy been disproved? , 2007, The Journal of clinical psychiatry.

[18]  A. Rush.  The varied clinical presentations of major depressive disorder. , 2007, The Journal of clinical psychiatry.

[19]  T. Madsen,et al.  Electroconvulsive therapy in melancholia: the role of hippocampal neurogenesis , 2007, Acta psychiatrica Scandinavica. Supplementum.

[20]  Edward Shorter,et al.  Melancholia: restoration in psychiatric classification recommended , 2007, Acta psychiatrica Scandinavica.

[21]  M. Fink,et al.  Resurrecting melancholia , 2007, Acta psychiatrica Scandinavica. Supplementum.

[22]  D. Klein,et al.  Atypical depression: current status and relevance to melancholia , 2007 .

[23]  W. Coryell.  The facets of melancholia , 2007, Acta psychiatrica Scandinavica. Supplementum.

[24]  W. A. Brown.  Treatment response in melancholia , 2007, Acta psychiatrica Scandinavica. Supplementum.

[25]  G. Parker,et al.  Defining melancholia: the primacy of psychomotor disturbance , 2007, Acta psychiatrica Scandinavica. Supplementum.

[26]  E. Shorter,et al.  The doctrine of the two depressions in historical perspective , 2007, Acta psychiatrica Scandinavica. Supplementum.

[27]  M. Fava,et al.  Clinical and demographic factors associated with DSM-IV melancholic depression. , 2006, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[28]  A. Rush,et al.  Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. , 2005, The Journal of clinical psychiatry.

[29]  K. Merikangas,et al.  Toward validation of atypical depression in the community: results of the Zurich cohort study. , 2002, Journal of affective disorders.

[30]  G. Parker,et al.  Atypical depression: a reappraisal. , 2002, The American journal of psychiatry.

[31]  A. Rush,et al.  ECT Remission Rates in Psychotic Versus Nonpsychotic Depressed Patients: A Report from CORE , 2001, The journal of ECT.

[32]  P. Mitchell,et al.  The differential impact of age on the phenomenology of melancholia , 2001, Psychological Medicine.

[33]  P. Sullivan,et al.  Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. , 2001, The Australian and New Zealand journal of psychiatry.

[34]  M. Guazzelli,et al.  Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia , 2000, International clinical psychopharmacology.

[35]  K. Behnke,et al.  A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression , 1999, Journal of psychopharmacology.

[36]  P. Perry.  Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. , 1996, Journal of affective disorders.

[37]  W. Sanderson,et al.  Atypical depression among psychiatric inpatients: clinical features and personality traits. , 1996, Journal of affective disorders.

[38]  A. Rush,et al.  The Inventory of Depressive Symptomatology (IDS): psychometric properties , 1996, Psychological Medicine.

[39]  S. Roose,et al.  Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. , 1994, The American journal of psychiatry.

[40]  J. Lonnqvist,et al.  Moclobemide and fluoxetine in atypical depression: a double-blind trial. , 1994, Journal of affective disorders.

[41]  A. Rush,et al.  Melancholic symptom features and DSM-IV. , 1994, The American journal of psychiatry.

[42]  R. Fieve,et al.  Melancholic/endogenous depression and response to somatic treatment and placebo. , 1992, The American journal of psychiatry.

[43]  M. Weissman,et al.  The validity of major depression with atypical features based on a community study. , 1992, Journal of affective disorders.

[44]  D. Klein,et al.  Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication. , 1990, Archives of general psychiatry.

[45]  G. Stanghellini,et al.  [Typus melancholicus from tellenbach up to the present day: a review about the premorbid personality vulnerable to melancholia]. , 2011, Actas espanolas de psiquiatria.

[46]  M. Thase.  Atypical Depression: Useful Concept, but it's Time to Revise the DSM-IV Criteria , 2009, Neuropsychopharmacology.

[47]  A. Leventhal,et al.  The empirical status of melancholia: implications for psychology. , 2005, Clinical psychology review.

[48]  M. Posternak,et al.  Partial validation of the atypical features subtype of major depressive disorder. , 2002, Archives of general psychiatry.

[49]  M. Escande,et al.  [Atypical depression]. , 1999, La Revue du praticien.

[50]  W. Sanderson,et al.  Atypical depression: clinical aspects and noradrenergic function. , 1995, The American journal of psychiatry.

[51]  P J McGrath,et al.  Atypical depression. A valid clinical entity? , 1993, The Psychiatric clinics of North America.

[52]  G. Tollefson,et al.  A double‐blind trial of fluoxetine, 20 mg, and placebo in out‐patients with DSM‐III-R major depression and melancholia , 1993, International clinical psychopharmacology.